Archive for January, 2009

Obese people at greater risk of Cancer

Saturday, January 31st, 2009

Fat predominantly deposited around the hips and buttocks doesn’t have this same risk Weight: lbs.  Fat dogs are more at risk in surgery, more prone to injury, and have more stress on heart, lungs, liver, kidneys, and joints.  Fats are energy sources; if the energy isn’t expended, fats merely add unneeded calories.  Fat content of dry food for adult dogs generally ranges between 11-16 percent, with sedentary dogs needing a lower percentage than active or performance dogs.

Obese people are sometimes thought to have lower metabolic rates than normal, meaning they need less food to maintain their weight.  Obese children should be evaluated for associated morbidity.  Obese children also have increased average blood pressure, heart rate and cardiac output when compared to non-obese peers.  Obese children are also more prone to skin disorders than are non-obese children, especially if deep skin folds are present. Obese children and teens are at greater risk for this painful hip problem.

Obese people had the most diabetes, and healthy people had the most strokes.  Obese women are frequently scorned as being out of control mental cases.  Obese men suffering from prostate cancer are two-and-a-half times more likely to die from it compared to normal-weight men, according to a recent study from Fred Hutchinson Cancer Research Center. Obese dogs have heavy fat over the ribs, along the spine, and around the tail.  Obese children also are twice as likely to have diabetes than children who are of normal weight, according to a new study from the University of Michigan Health System.

Acomplia pills are in the UK

Saturday, January 31st, 2009

Acomplia pills are the newest entrant in the UK pharmaceutical market making waves for its dual nature of weight loss and smoking cessation property.  it is recommended as an addition to exercise and proper diet for obese and overweight patients who found two other weight-loss medications Reductil (orlistat) and Xenical (sibutramine) ineffective.  Iy belongs to the new class of therapeutic agents known as Cannabinoid-1 (CB1).

Acomplia selectively blocks CB1 receptors of brain and peripheral organs that account for glucose and fat metabolism.  which was to have been marketed in the United States as Zimulti, was withdrawn from FDA consideration last June after an expert panel unanimously recommended against approval out of concern over depressive and suicidal side-effects.   It also has smoking cessation benefits but it is not yet approved for this purpose.  rimonabant received approval in the UK on 28th of June 2006 but its FDA approval for US is still pending.

Acomplia is an anorectic anti-obesity drug and works as cannabinoid-1 receptor antagonist.  it is an appetite suppressant and blocks CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle are you with increase in waist size buy Buy Xenical Diet Pills, excessive fat that are stored around the middle of the body Buy Slimfast (Buy generic Meridia, generic Reductil contains Sibutramine 10 mg Sibutramine, a large waist Buy Slimona is also effective against certain metabolic disorders and associated cardiovascular risk factors.